COVID-19 Implications for Patients with CLL: Living Slideset

Download this living slideset from the live Webinar on the management of patients with CLL during the COVID-19 pandemic and check back often for updates as the situation evolves and more data are available.
Jacqueline Barrientos, MD, MS
Nicole Lamanna, MD
John Pagel Headshot
John Pagel, MD, PhD
person default
Jacob D. Soumerai, MD
Format: Microsoft PowerPoint (.ppt)
File Size: 1.60 MB
Released: July 2, 2020

Acknowledgements

Provided by Clinical Care Options, LLC.

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Supported by an educational grant from
AstraZeneca

Related Content

Nicole Lamanna, MD, on modifying CLL treatment during COVID-19 pandemic, IVIg as COVID-19 prophylaxis, and the role of BTK inhibition, from CCO

Nicole Lamanna, MD Released: September 14, 2020

Commentary from Dr. Brian Koffman, of the CLL Society, on counseling patients with CLL to protect their physical and mental health during COVID-19, from CCO

Brian Koffman, MDCM (retired), MS Ed Released: August 31, 2020

Dr. Jacqueline Barrientos shares her experiences managing patients with CLL during the COVID-19 pandemic in NYC and offers recommendations, from CCO

Jacqueline Barrientos, MD, MS Released: August 11, 2020

John Pagel, MD, PhD discusses incorporating telemedicine and other strategies into the care plan for patients with CLL during COVID-19

John Pagel Headshot John Pagel, MD, PhD Released: July 13, 2020

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue